David F Hale, a director of Biocept, recently acquired 50,000 shares of the company. The buys took place at $1.00 per share, on May 04, 2016. Hale now owns 232,926 shares of the company. Hale operates out of San Diego, CA. Some additional info was provided as follows:
Shares were purchased from the issuer in a unit offering, with each unit consisting of one share of Common Stock and one warrant to purchase .70 shares of Common Stock for $1.00 per unit.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Biocept makes a similar move, sign up!
Other recent filings from the company include the following:
Biocept Just Filed Its Quarterly Report:
10. Net Loss per Co... - May 15, 2017
Securities to be offered to employees in employee benefit plans - May 15, 2017
Biocept Reports First Quarter 2017 Financial Results - May 11, 2017
Biocept: With Respect To Restricted Awards, The Restricted Period Sha - May 5, 2017